Marcaje de ceftizoxima con 99mTc

Gomes Barreto, V; Iglesias, F; Roca, M; Tubau, F; Martín Comín, J.
Rev. esp. med. nucl. (Ed. impr.) ; 19(7): 479-483, nov. 2000.
Artículo en Es | IBECS (España) | ID: ibc-5826

Documentos relacionados

  1. [Phase I clinical trial on the safety of injectable cefetamet sodium with a single dose in healthy volunteers].
  2. Impact of different organic acids on solubility enhancement of cefpodxime proxetil immediate release tablet and its stability studies.
  3. A SIMPLE AND-SENSITIVE STABILITY-INDICATING UHPLC-DAD METHOD FOR THE DETERMINATION OF CEFETAMET PIVOXIL HYDROCHLORIDE.
  4. Cefpodoxime proxetil.
  5. Clinical Trial to Reconfirm the Efficacy and Safety of Cefetamet Pivoxil Treatment in Sinusitis Patients: A Double-Blind, Randomized, Parallel Designed, Multicenter, Active Comparator Study (CASIS Study).
  6. Study of the structure and dynamics at various parts of the antibacterial drug molecule cefpodoxime proxetil.
  7. Effects of antibiotics on prevention of infection, white blood cell counts, and C-reactive protein levels at different times in the perioperative period of cesarean section
.
  8. Development and validation of HPLC method for the determination of Cefpodoxime Proxetil in human plasma.
  9. Development and validation of RP-HPLC method for simultaneous determination of cefpodoxime proxetil and H2 receptor antagonists in pharmaceutical dosage forms.
  10. Adsorptive properties of cefpodoxime proxetil as a tool for a new method of its determination in urine.